94 related articles for article (PubMed ID: 7576000)
21. Importance of immunoglobulin isotype in therapy of experimental autoimmune encephalomyelitis with monoclonal anti-CD4 antibody.
Waldor MK; Mitchell D; Kipps TJ; Herzenberg LA; Steinman L
J Immunol; 1987 Dec; 139(11):3660-4. PubMed ID: 3500226
[TBL] [Abstract][Full Text] [Related]
22. CD8⁺ T cell help is required for efficient induction of EAE in Lewis rats.
Camara M; Beyersdorf N; Fischer HJ; Herold MJ; Ip CW; van den Brandt J; Toyka KV; Taurog JD; Hünig T; Herrmann T; Reichardt HM; Weishaupt A; Kerkau T
J Neuroimmunol; 2013 Jul; 260(1-2):17-27. PubMed ID: 23664330
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune effector cells. VIII. Cellular requirements for the induction of autoreactive T cells of experimental allergic encephalomyelitis in nonimmune rats.
Silberg DG; Swanborg RH
J Immunol; 1986 Apr; 136(7):2432-6. PubMed ID: 3485150
[TBL] [Abstract][Full Text] [Related]
24. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.
Beyersdorf N; Gaupp S; Balbach K; Schmidt J; Toyka KV; Lin CH; Hanke T; Hünig T; Kerkau T; Gold R
J Exp Med; 2005 Aug; 202(3):445-55. PubMed ID: 16061730
[TBL] [Abstract][Full Text] [Related]
25. CD4 microglial expression correlates with spontaneous clinical improvement in the acute Lewis rat EAE model.
Almolda B; Costa M; Montoya M; González B; Castellano B
J Neuroimmunol; 2009 Apr; 209(1-2):65-80. PubMed ID: 19246105
[TBL] [Abstract][Full Text] [Related]
26. T cell requirement for experimental allergic encephalomyelitis induction in the rat.
Ortiz-Ortiz L; Nakamura RM; Weigle WO
J Immunol; 1976 Aug; 117(2):576-9. PubMed ID: 1084904
[TBL] [Abstract][Full Text] [Related]
27. Identification of CD4- CD8- alpha beta T cells in the subarachnoid space of rats with experimental autoimmune encephalomyelitis. A possible route by which effector cells invade the lesions.
Tsuchida M; Hanawa H; Hirahara H; Watanabe H; Matsumoto Y; Sekikawa H; Abo T
Immunology; 1994 Mar; 81(3):420-7. PubMed ID: 8206516
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
Hilliard BA; Kamoun M; Ventura E; Rostami A
Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
[TBL] [Abstract][Full Text] [Related]
29. Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis.
Wildbaum G; Youssef S; Grabie N; Karin N
J Immunol; 1998 Dec; 161(11):6368-74. PubMed ID: 9834127
[TBL] [Abstract][Full Text] [Related]
30. Experimental allergic encephalomyelitis and vaccination-induced resistance in DA rats.
Bouwer HG; Hinrichs DJ
Cell Immunol; 1997 Jan; 175(1):92-8. PubMed ID: 9015193
[TBL] [Abstract][Full Text] [Related]
31. Analysis of V beta 8.2 CDR3 sequences from spinal cord T cells of Lewis rats vaccinated or treated with TCR V beta 8.2-39-59 peptide.
Buenafe AC; Vainiene M; Celnik B; Vandenbark AA; Offner H
J Immunol; 1995 Aug; 155(3):1556-64. PubMed ID: 7636217
[TBL] [Abstract][Full Text] [Related]
32. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells.
Brostoff SW; Mason DW
J Immunol; 1984 Oct; 133(4):1938-42. PubMed ID: 6236260
[TBL] [Abstract][Full Text] [Related]
33. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions.
Sun D; Qin Y; Chluba J; Epplen JT; Wekerle H
Nature; 1988 Apr; 332(6167):843-5. PubMed ID: 2965794
[TBL] [Abstract][Full Text] [Related]
34. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats.
Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y
Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796
[TBL] [Abstract][Full Text] [Related]
35. Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide--mechanisms independent of pyrimidine depletion.
Korn T; Magnus T; Toyka K; Jung S
J Leukoc Biol; 2004 Nov; 76(5):950-60. PubMed ID: 15328336
[TBL] [Abstract][Full Text] [Related]
36. Induction of experimental autoimmune encephalomyelitis in severe combined immunodeficient mice reconstituted with allogeneic or xenogeneic hematopoietic cells.
Jones RE; Bourdette DN; Whitham RH; Offner H; Vandenbark AA
J Immunol; 1993 May; 150(10):4620-9. PubMed ID: 8097758
[TBL] [Abstract][Full Text] [Related]
37. Short term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis: treatment abrogates autoimmune disease but not autoimmunity.
Willenborg DO; Staykova MA; Miyasaka M
J Immunol; 1996 Sep; 157(5):1973-80. PubMed ID: 8757317
[TBL] [Abstract][Full Text] [Related]
38. CD8+ T cells in inflammatory demyelinating disease.
Weiss HA; Millward JM; Owens T
J Neuroimmunol; 2007 Nov; 191(1-2):79-85. PubMed ID: 17920696
[TBL] [Abstract][Full Text] [Related]
39. [The role of T-lymphocyte subsets in susceptibility and resistance to induction of autoimmunity in the central nervous system].
Mostarica-Stojković M; Vukmanović S; Radojković M; Ramić Z; Vucković S; Ejdus L; Pravica V; Simić MM; Lukić ML
Glas Srp Akad Nauka Med; 1994; (44):35-43. PubMed ID: 7590413
[TBL] [Abstract][Full Text] [Related]
40. Immunoregulation of passively induced allergic encephalomyelitis.
Willenborg DO; Sjollema P; Danta G
J Immunol; 1986 Mar; 136(5):1676-9. PubMed ID: 2936807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
